Your browser doesn't support javascript.
US and Canada to roll out the first omicron specific boosters within days
BMJ : British Medical Journal (Online) ; 378, 2022.
Article in English | ProQuest Central | ID: covidwho-2020004
ABSTRACT
The Food and Drug Administration (FDA) authorised updated boosters from Pfizer BioNTech and from Moderna on 31 August, and an expert advisory committee convened the next day by the Centers for Disease Control and Prevention (CDC) voted 13-1 to recommend their use. A projection shown to the experts estimated that waiting to roll out the new boosters until November, when more human data will be available could have resulted in 9700 more deaths and 137 000 more hospital admissions.1 Canada approves older omicron booster Health Canada on 1 September approved for adults Moderna’s bivalent booster that targets the omicron BA.1 variant. BA.1 disappeared from circulation in May, but Canada’s National Advisory Committee on Immunization said the new booster will generate a significantly more effective neutralising antibody response against BA.4 and BA.5 than the original Moderna vaccine.
Keywords

Full text: Available Collection: Databases of international organizations Database: ProQuest Central Topics: Vaccines / Variants Language: English Journal: BMJ : British Medical Journal (Online) Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: ProQuest Central Topics: Vaccines / Variants Language: English Journal: BMJ : British Medical Journal (Online) Year: 2022 Document Type: Article